ズエリック・ファーマ、韓国に治験サポートセンターを開設

The establishment of this innovation center in South Korea positions it as a key hub for clinical research in APAC.

Sunday, November 30, 2025
2 min read
Zuellig Pharma Newsroom
正規ソース
South Korea
Full Analysis90%
LinkedInX
変更点

Opened a new Clinical Trial Support Innovation Center in South Korea to enhance research capabilities.

Source Report

Zuellig Pharma 在韩国揭幕了其最先进的临床试验支持创新中心。该设施旨在通过提供先进的基础设施和服务,支持韩国国内及全球的临床研究工作。该中心致力于加速药物研发,并提高在韩国市场内外进行的临床试验效率。

Sigvera Intelligence
1New Clinical Trial Support Innovation Center launched in South Korea.
2Aims to support domestic and global clinical research.
3Enhances infrastructure for drug development in APAC.
Market Impact

The establishment of this innovation center in South Korea positions it as a key hub for clinical research in APAC. It will support the development of new medicines by providing cutting-edge infrastructure and services, thereby contributing to the region's growing biopharmaceutical ecosystem and accelerating the availability of novel treatments for patients.

地域的視点

This investment in South Korea enhances the region's capacity for advanced clinical research, supporting global pharmaceutical innovation and potentially leading to faster access to new therapies for APAC populations.

Healthtech & Biotech

Where this signal fits in the broader landscape.

72 業界シグナルInfrastructure
すべて見る
Verified from official source
PublisherZuellig Pharma Newsroom
公開日Nov 30, 2025
ソースタイプCompany Newsroom
ソース分類Verified Canonical
シグナルタイムライン
初回報道Nov 30, 2025
インデックスMar 10, 2026
公開Mar 10, 2026

https://finance.yahoo.com/news/zuellig-pharma-unveils-state-art-023000313.html

Read Full Source
信頼度:75%
Get cross-language signal intelligence

Get curated intelligence delivered to your inbox. No spam, unsubscribe anytime.

Sign in to save notes on signals.

ログイン
業界Healthtech & Biotech地域South KoreaイベントInfrastructureソース公式

Stay ahead of the next signal.

Free weekly briefings with structured signal summaries. No spam, cancel anytime.